Engineered immunomodulatory extracellular vesicles derived from epithelial cells acquire capacity for positive and negative T cell co-stimulation in cancer and autoimmunity
Kugeratski, F.; LeBleu, V.; Dowlatshahi, D.; Sugimoto, H.; Arian, K.; Fan, Y.; Huang, L.; Wills, D.; Lilla, S.; Hodge, K.; Zanivan, S.; McAndrews, K.; Kalluri, R.
Show abstract
Extracellular vesicles (EVs) are generated by all cells and systemic administration of allogenic EVs derived from epithelial and mesenchymal cells have been shown to be safe, despite carrying an array of functional molecules, including thousands of proteins. To address whether epithelial cells derived EVs can be modified to acquire the capacity to induce immune response, we engineered 293T EVs to harbor the immunomodulatory CD80, OX40L and PD-L1 molecules. We demonstrated abundant levels of these proteins on the engineered cells and EVs. Functionally, the engineered EVs efficiently elicit positive and negative co-stimulation in human and murine T cells. In the setting of cancer and auto-immune hepatitis, the engineered EVs modulate T cell functions and alter disease progression. Moreover, OX40L EVs provide additional benefit to anti-CTLA-4 treatment in melanoma-bearing mice. Our work provides evidence that epithelial cell derived EVs can be engineered to induce immune responses with translational potential to modulate T cell functions in distinct pathological settings.
Matching journals
The top 9 journals account for 50% of the predicted probability mass.
Similar papers in this journal
- Desmoplastic stroma restricts T cell extravasation and mediates immune exclusion and immunosuppression in solid tumors 96%
- Agonistic CD40 antibody therapy induces tertiary lymphoid structures but impairs the response to immune checkpoint blockade in glioma 96%
- Ending transmission of SARS-CoV-2: sterilizing immunity using an intranasal subunit vaccine 96%
Similar papers in this journal
- A new universal chimeric-antigen receptor (CAR)- fragment antibody binder (FAB) split system for cancer immunotherapy 96%
- Immune engineered extracellular vesicles to modulate T cell activation in the context of type 1 diabetes 95%
- Simultaneous analysis of pMHC binding and reactivity unveils virus-specific CD8 T cell immunity to a concise epitope set 95%
Similar papers in this journal
- Tim4 enables large peritoneal macrophages to cross-present tumor antigens at early stages of tumorigenesis 95%
- Stromal remodeling regulates dendritic cell abundance and activity in the tumor microenvironment 95%
- Neoantigen Cancer Vaccines and Different Immune Checkpoint Therapies Each Utilize Both Converging and Distinct Mechanisms that in Combination Enable Synergistic Therapeutic Efficacy 95%
Similar papers in this journal
- Bioengineering multifunctional extracellular vesicles for targeted delivery of biologics to T cells 96%
- In vivo affinity maturation of the HIV-1 Env-binding domain of CD4 96%
- Collagen-binding IL-12 expressing STEAP1 CAR-T cells reduce toxicity and eradicate mouse prostate cancer in combination with checkpoint inhibitors 96%
Similar papers in this journal
- Tumour Extracellular Vesicles Induce Neutrophil Extracellular Traps To Promote Lymph Node Metastasis 94%
- Binding of phosphatidylserine-positive microparticles by PBMCs classifies disease severity in COVID-19 patients 93%
- Snorkel-tag Based Affinity Chromatography for Recombinant Extracellular Vesicle Purification 93%
"Similar papers" are the closest papers from that journal in the model's embedding space. They show what the match is built on, but the ranking comes mostly from a classifier over the whole training set, not from these examples alone.